S. Shirodkar, M. Ewen, J.A. DeCaprio, J. Morgan, D.M. Livingston, T. Chittenden, "The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner," Cell, 68:157- 66, 1992.

Thomas Chittenden (Immunogen Inc., Cambridge, Mass.): "This work was done in the lab of David M. Livingston at the Dana- Farber Cancer Institute in Boston. The retinoblastoma protein (Rb) belongs to a class of growth regulatory proteins, termed tumor suppressors, which function to prevent tumorigenesis. Livingston's laboratory has been interested in understanding, at a molecular level, how Rb negatively regulates cell growth. In 1991 several groups, including our own, demonstrated that Rb forms a complex with the cellular transcription factor E2F. E2F contributes to the cell cycle-dependent transcription of a multitude of genes involved in DNA synthesis and cell proliferation.

"This work is an effort to understand how the activity of E2F is coordinated with...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?